[(3R,8R,9R,10R,12R,13S,14S,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] acetate

Details

Top
Internal ID c23cda40-ece3-4e03-89a9-ec67131c8ec2
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name [(3R,8R,9R,10R,12R,13S,14S,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] acetate
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C42H66O16/c1-20-35(47)29(51-8)18-34(52-20)58-37-22(3)54-33(17-28(37)46)57-36-21(2)53-32(16-27(36)45)56-26-10-11-38(6)25(15-26)9-12-41(49)30(38)19-31(55-24(5)44)39(7)40(48,23(4)43)13-14-42(39,41)50/h9,20-22,26-37,45-50H,10-19H2,1-8H3/t20-,21-,22-,26-,27-,28-,29-,30-,31-,32+,33+,34+,35-,36-,37-,38+,39-,40-,41-,42+/m1/s1
InChI Key OQIBAKBNODPWBP-AGUVAUEVSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C42H66O16
Molecular Weight 827.00 g/mol
Exact Mass 826.43508601 g/mol
Topological Polar Surface Area (TPSA) 229.00 Ų
XlogP 0.40
Atomic LogP (AlogP) 1.70
H-Bond Acceptor 16
H-Bond Donor 6
Rotatable Bonds 9

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(3R,8R,9R,10R,12R,13S,14S,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5S,6R)-4-hydroxy-5-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8916 89.16%
Caco-2 - 0.8806 88.06%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.7413 74.13%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8598 85.98%
OATP1B3 inhibitior + 0.9150 91.50%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6874 68.74%
BSEP inhibitior + 0.9366 93.66%
P-glycoprotein inhibitior + 0.7533 75.33%
P-glycoprotein substrate + 0.7012 70.12%
CYP3A4 substrate + 0.7366 73.66%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8939 89.39%
CYP3A4 inhibition - 0.8774 87.74%
CYP2C9 inhibition - 0.9072 90.72%
CYP2C19 inhibition - 0.9239 92.39%
CYP2D6 inhibition - 0.9465 94.65%
CYP1A2 inhibition - 0.8810 88.10%
CYP2C8 inhibition + 0.5705 57.05%
CYP inhibitory promiscuity - 0.9725 97.25%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5449 54.49%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.9128 91.28%
Skin irritation + 0.5454 54.54%
Skin corrosion - 0.9191 91.91%
Ames mutagenesis - 0.5770 57.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7352 73.52%
Micronuclear - 0.7000 70.00%
Hepatotoxicity - 0.6125 61.25%
skin sensitisation - 0.8738 87.38%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity + 0.9778 97.78%
Mitochondrial toxicity + 0.8625 86.25%
Nephrotoxicity - 0.8336 83.36%
Acute Oral Toxicity (c) II 0.3208 32.08%
Estrogen receptor binding + 0.8260 82.60%
Androgen receptor binding + 0.7576 75.76%
Thyroid receptor binding - 0.5387 53.87%
Glucocorticoid receptor binding + 0.7405 74.05%
Aromatase binding + 0.6912 69.12%
PPAR gamma + 0.7957 79.57%
Honey bee toxicity - 0.6298 62.98%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity + 0.5800 58.00%
Fish aquatic toxicity + 0.9600 96.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.66% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.17% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.01% 91.11%
CHEMBL241 Q14432 Phosphodiesterase 3A 91.66% 92.94%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.65% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 91.48% 100.00%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 91.03% 91.07%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.91% 97.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.89% 86.33%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.61% 94.00%
CHEMBL2581 P07339 Cathepsin D 86.35% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.60% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.42% 95.56%
CHEMBL5255 O00206 Toll-like receptor 4 83.27% 92.50%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.00% 92.62%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 82.54% 97.14%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.42% 95.89%
CHEMBL5028 O14672 ADAM10 81.80% 97.50%
CHEMBL2413 P32246 C-C chemokine receptor type 1 81.59% 89.50%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.11% 95.89%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Asclepias incarnata

Cross-Links

Top
PubChem 162870941
LOTUS LTS0240222
wikiData Q105196833